Preliminary validation of a structural magnetic resonance imaging metric for tracking dementia-related neurodegeneration and future decline

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and atrophy in the medial temporal lobe (MTL) and subsequent brain regions. Structural magnetic resonance imaging (sMRI) has been widely used in research and clinical care for diagnosis and monitor...

全面介紹

書目詳細資料

發表在:	NeuroImage: Clinical
Main Authors:	Gavin T. Kress, Emily S. Popa, Paul M. Thompson, Susan Y. Bookheimer, Sophia I. Thomopoulos, Christopher R.K. Ching, Hong Zheng, Daniel A. Hirsh, David A. Merrill, Stella E. Panos, Cyrus A. Raji, Prabha Siddarth, Jennifer E. Bramen
格式:	Article
語言:	英语
出版:	Elsevier 2023-01-01
主題:	Mild cognitive impairment Alzheimer’s disease Dementia Magnetic resonance imaging Biomarker
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S221315822300147X